# Effect of IV Iron in Patients With Heart Failure With Preserved Ejection Fraction

> **NCT03074591** · PHASE4 · COMPLETED · sponsor: **Charite University, Berlin, Germany** · enrollment: 40 (actual)

## Conditions studied

- Iron-deficiency
- Heart Failure

## Interventions

- **DRUG:** Ferric Carboxymaltose 50Mg/Ml Inj 15Ml
- **DRUG:** Saline Solution for Injection

## Key facts

- **NCT ID:** NCT03074591
- **Lead sponsor:** Charite University, Berlin, Germany
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-08-01
- **Primary completion:** 2022-12-13
- **Final completion:** 2024-04-10
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2024-05-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03074591

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03074591, "Effect of IV Iron in Patients With Heart Failure With Preserved Ejection Fraction". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03074591. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*